Video Gallery


Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Pancreatic cancer overview and how to improve survival rates – Prof. Marco Del Chiaro; Karolinska University Hospital, Sweden.

 


Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
IMMray™ Biomarker signatures history and development – Prof Carl Borrebaeck, CREATE Health, Lund

 


Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Pancreatic cancer – from a patient perspective – PALEMA, Swedish patient support organization, Carl Hamilton

 


Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Pancreatic cancer – from a patient perspective – Pancreasnetværket, Danish patient organization, Poul Ejby Rasmussen

 


Presentation from World Pancreatic Cancer Day in Lund, November 17, 2016:
Early detection of pancreatic cancer with IMMray™ PanCan-d – PhD. Laura Chirica, CCO, Immunovia AB

 


Immunovia presentation from Oslo Life Science 2017, Feb. 16
Diagnosis of early stages of pancreatic cancer – Laura Chirica, CCO, Immunovia AB

 


World Pancreatic Cancer Day Lund Sweden, November 17, 2016:
We united and made our voices heard in the battle against pancreatic cancer during ”World pancreatic cancer day”

 


IMMray™ technology:
IMMray™ PanCan–d is the first blood-based test for early and specific (differential) diagnosis, providing clinicians with actionable information. Immunovia has defined a clinically relevant condensed panel of serum biomarkers (a biomarker signature) associated with pancreatic adenocarcinoma.

 


IMMray™ technology – Short Version:
IMMray™ PanCan–d is the first blood-based test for early and specific (differential) diagnosis, providing clinicians with actionable information. Immunovia has defined a clinically relevant condensed panel of serum biomarkers (a biomarker signature) associated with pancreatic adenocarcinoma.